BiotechTubeBiotechTube
Home/Pipeline/VIP236

VIP236

Advanced Solid Tumors

Phase 1Active

Key Facts

Indication
Advanced Solid Tumors
Phase
Phase 1
Status
Active
Company
Vincerx Pharma

About Vincerx Pharma

Vincerx Pharma is dedicated to accelerating the development of life-changing medicines for cancer patients with high unmet needs. The company employs a capital-efficient, virtual R&D model to advance a diverse pipeline of small molecules and biologics, including both proprietary and in-licensed assets. Its strategy focuses on strategic partnerships and targeted clinical development to maximize the potential of its oncology portfolio. Vincerx aims to address significant market opportunities in oncology through precision medicine approaches.

View full company profile

Therapeutic Areas

Oncology

Other Advanced Solid Tumors Drugs

DrugCompanyPhase
SHR-1701Jiangsu Hengrui MedicinePhase 1
BAY 1895344BayerPhase 1
HS-10342Hansoh PharmaPhase 1/2
ANKTIVA® + M-ceNKImmunityBioPhase 1
DFTX-101Definium TherapeuticsPhase 1/2
REC-617Recursion PharmaceuticalsPhase 1/2
ZW220ZymeworksPreclinical
NX-1607Nurix TherapeuticsPhase 1a
IMA402 (TCR Bispecific)ImmaticsPhase 1
IMA403 (TCR Bispecific)ImmaticsPre-clinical
BCA101Bicara TherapeuticsPhase 1
AN4005Adlai NortyePreclinical